Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.42 +0.01 (+2.17%)
At close: Oct 23, 2026 · 4:00 PM EDT

Biodexa Pharmaceuticals (BDRX) Non Operating Investment Income (2016 - 2018)

Updated

Analysis

Biodexa Pharmaceuticals (BDRX) Non Operating Investment Income (2016 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Biodexa Pharmaceuticals 4,043.45 -23.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -1.81 Mn
Dec 31, 2017 -1.87 Mn
Dec 31, 2016 -1.75 Mn
API Access

Biodexa Pharmaceuticals Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=BDRX&period=max&api_key=YOUR_API_KEY